IRCT2015030921388N1
Completed
未知
A clinical trial study in treatment of children with gastroesophageal reflux disease symptoms: Cydonia oblonga syrup versus omeprazole syrup
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Pediatric gastro-oesophageal reflux disease.
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •children more than one month and less than 18 years old; signed an informed consent form by parents; Vomiting immediately after eating; restlessness for one to three hours after feeding; respiratory distress after feeding; the lack of weight gain; refusing to eat; endoscopically proven gasteroeshophageal reflux disease.
- •Exclusion criteria: Children younger than 1 month and older than 18 years old; those who need to use other oral or intravenous drugs; unwillingness to continue to participate in the study; sensitivity to study drugs; patients with other gasteroeshophageal disorders such as esophagitis and peptic ulcer; patients with active renal, liver and neurological diseases; mental retardation; pregnancy; lactation and disability of parents/guardian to cooperate in filling the forms (cognitive or language disorder).
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma.Hepatoblastoma and liver cancer (hepatocarcinoma)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2023-000036-30-PLMedical University of Gdansk60
Active, not recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic LeukemiaEUCTR2017-002383-40-ITAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Active, not recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic LeukemiaEUCTR2017-002383-40-CZAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Active, not recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemiaacute promyelocytic leukemia (APL) in children and adolescentsTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-002383-40-SEAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Not yet recruiting
Phase 2
Treatment study for children and adolescents with Acute Promyelocytic LeukemiaNL-OMON54336AIEOP- Associazione Italiana Ematologia Oncologia Pediatrica5